In a study released June 6, 2012 through the online journal Behavioral and Brain Functions, researchers from Japan acknowledge that “the results of association studies to date argue against the NGM (nuclear genome model), and in its place the MGM (mitochondrial genome model) is emerging as a viable option to account for genomic and pathophysiological research findings involving SCZ (schizophrenia).”
Article → Note from Kermit Cole, “In the News” editor:
Along with epigenetic research, it seems that the search for some attributable genetic linkage is ongoing. Michael Cornwall will be blogging on the implications of the widening search.
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.